Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

BACKGROUND: The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings. METHODS: We retrospectively reviewed 436 patients with pT1-3N0-2M0 RCC w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Taguchi, Satoru, Buti, Sebastiano, Fukuhara, Hiroshi, Otsuka, Masafumi, Bersanelli, Melissa, Morikawa, Teppei, Miyazaki, Hideyo, Nakagawa, Tohru, Fujimura, Tetsuya, Kume, Haruki, Igawa, Yasuhiko, Homma, Yukio
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2017
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5328261/
https://ncbi.nlm.nih.gov/pubmed/28241027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0172341
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki